AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2019
Nov 15, 2019
33298_dirs_2019-11-15_7d81f3a7-cdeb-4490-95a6-2aa5d716ad54.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2019-11-14
Reporting Person: Schreiber Justin (Director, Chief Executive Officer, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-14 | Common Stock, par value $0.01 | P | 13262 | $0.1685 | Acquired | 9417572 | Indirect |
| 2019-11-14 | Common Stock, par value $0.01 | P | 5000 | $0.167 | Acquired | 9422572 | Indirect |
| 2019-11-14 | Common Stock, par value $0.01 | P | 461 | $0.1698 | Acquired | 9423033 | Indirect |
| 2019-11-14 | Common Stock, par value $0.01 | P | 6277 | $0.1698 | Acquired | 9429310 | Indirect |
| 2019-11-14 | Common Stock, par value $0.01 | P | 26700 | $0.167 | Acquired | 9456010 | Indirect |
| 2019-11-14 | Common Stock, par value $0.01 | P | 18300 | $0.164 | Acquired | 9474310 | Indirect |
| 2019-11-14 | Common Stock, par value $0.01 | P | 5000 | $0.164 | Acquired | 9479310 | Indirect |
Footnotes
F1: These shares were purchased on the open market.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17